LeMaitre Vascular Reports 10% Revenue Growth to $70.4 Million in Q2 2026

LeMaitre Vascular, Inc. reported a notable increase in financial performance for the second quarter of 2026, with net sales reaching $70.4 million, a 10% rise from $64.2 million in the same period of 2025. For the first half of 2026, the company recorded total revenues of $136.9 million, up from $124.1 million year-over-year. The gross profit for the quarter was $50.8 million, reflecting a gross margin of 72.1%, compared to 70.0% in the prior year. The increase in revenue was attributed to higher average selling prices and increased unit volumes, particularly in graft and shunt sales, alongside the European launch of the Artegraft product.

In terms of profitability, LeMaitre reported a net income of $17.1 million for the second quarter, up from $13.8 million in the same quarter of 2025. For the six-month period, net income was $32.7 million, compared to $24.8 million in the previous year. The earnings per share for the second quarter were $0.75 on a basic basis, an increase from $0.61 in the prior year. The company also declared a quarterly cash dividend of $0.25 per share, reflecting a commitment to returning value to shareholders.

Operationally, LeMaitre has made significant strides in expanding its market presence. The company’s direct sales force now comprises 163 representatives across North America, Europe, and the Asia Pacific region, with approximately 95% of net sales generated through direct-to-hospital sales. The company has also been actively pursuing acquisitions to enhance its product offerings, including the recent agreement to acquire the AndraValvulotome business from Andramed GmbH for $1.8 million, with additional contingent payments based on regulatory approvals.

Geographically, LeMaitre experienced strong sales growth in Europe, with a reported 18% increase in net sales for the second quarter, driven by higher sales of grafts and shunts. The Americas saw a more modest growth of 5%, while the Asia Pacific region also reported an 18% increase. The company’s strategic focus on expanding its direct sales capabilities and entering new markets is expected to continue driving growth. Looking ahead, LeMaitre anticipates further revenue growth, supported by its ongoing product development initiatives and geographic expansion efforts, while also managing costs and operational efficiencies to maintain profitability.